RICE HALL JAMES & ASSOCIATES, LLC
Position in PCRX — Pacira BioSciences, Inc.
CIK 1230765
San Diego, CA
Position in PCRX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,369,456
+$361,582 QoQ
Shares Held
93,396
+5.1% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#62
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026RICE HALL JAMES & ASSOCIATES, LLC holds $193,433,636 across 12 Drug Manufacturers - Specialty & Generic names. PCRX ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
624,928 | $39,964,145 | |
| 2 | PBH |
Prestige Consumer Healthcare Inc.
|
689,692 | $32,601,740 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,332,043 | $23,320,430 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
490,221 | $22,800,178 | |
| 5 | ALKS |
Alkermes plc.
|
390,866 | $20,481,378 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
100,195 | $16,886,865 | |
| 7 | HROW |
Harrow, Inc.
|
387,545 | $16,459,036 | |
| 8 | EOLS |
Evolus, Inc.
|
1,289,888 | $8,951,822 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,369,456 | 93,396 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,007,874 | 88,844 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,690,879 | 181,255 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,107,670 | 237,007 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $6,220,859 | 260,287 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $6,399,073 | 257,508 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,901,885 | 260,185 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $4,038,471 | 268,337 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $28,570,661 | 998,625 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $30,492,238 | 1,043,540 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $34,953,594 | 1,035,969 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $29,713,119 | 968,485 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $36,335,676 | 906,805 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $30,346,152 | 743,596 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $16,883,573 | 437,285 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $21,695,030 | 407,878 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $24,723,864 | 424,080 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $34,862,823 | 456,798 | Shares | Sole | 2022-05-26 | |
| 2021-12-31 | $25,283,734 | 420,205 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,701,144 | 333,949 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $20,053,708 | 330,483 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $38,521,183 | 549,596 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $33,147,410 | 553,934 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $34,473,288 | 573,408 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $32,196,379 | 613,615 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $21,047,250 | 627,714 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||